Mingli L. Peng

The Key Laboratory Of Molecular Biology For Infectious Diseases, 76# Linjiang Road, Yuzhong District
Linjiang, 400010, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Multi-Omics Integration Uncovers That Tenofovir Disoproxil Fumarate Is Linked to Hepatic Metabolic Reprogramming Independent of Viral Infection.

Multi-Omics Integration Uncovers That Tenofovir Disoproxil Fumarate Is Linked to Hepatic Metabolic Reprogramming Independent of Viral Infection.

Journal: Life (Basel, Switzerland)

Published: April 28, 2026

Natural small molecule evodiamine alleviates liver fibrosis by targeting the ANXA2-p110α axis in hepatic stellate cells.

Natural small molecule evodiamine alleviates liver fibrosis by targeting the ANXA2-p110α axis in hepatic stellate cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 01, 2026

Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg.

Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg.

Journal: Frontiers in cellular and infection microbiology

Published: February 04, 2026

Unaddressed Limitations of Alanine Aminotransferase as a Screening Tool for Pediatric Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease.

Unaddressed Limitations of Alanine Aminotransferase as a Screening Tool for Pediatric Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 29, 2026

Genomic and transcriptomic features of HBV integration in treatment-naïve, HBeAg-positive children with chronic HBV infection.

Genomic and transcriptomic features of HBV integration in treatment-naïve, HBeAg-positive children with chronic HBV infection.

Journal: EBioMedicine

Published: October 30, 2025

Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B.

Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B.

Journal: Gut

Published: August 08, 2025

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study.

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study.

Journal: Virology journal

Published: November 09, 2024

Clinical Characteristics During and After COVID-19 Infection Among Healthcare Workers During the First Wave of Omicron in Chongqing, China.

Clinical Characteristics During and After COVID-19 Infection Among Healthcare Workers During the First Wave of Omicron in Chongqing, China.

Journal: Immunity, inflammation and disease

Published: September 06, 2024

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients.

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients.

Journal: Frontiers in pharmacology

Published: February 04, 2024

A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.

A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.

Journal: Journal of medical virology

Published: January 03, 2024

Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.

Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.

Journal: Journal of medical virology

Published: December 02, 2023

Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.

Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.

Journal: Journal of medical virology

Published: October 20, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026